Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing L. Bissonnette, M.G. Bergeron Clinical.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Clinical and microbiological outcome in septic patients with extremely low 25- hydroxyvitamin D levels at initiation of critical care G. De Pascale, M.S.

O. Clerc, G. Greub Clinical Microbiology and Infection

M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Non-antibiotic strategies for sepsis

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Surveillance of Legionnaires’ disease in Austria

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Sepsis and neutropenia induced by clozapine

Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective.

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

G.R. Davies Clinical Microbiology and Infection

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Molecular identification of Acinetobacter sp

Statin use and clinical outcomes among pneumonia patients

O. Clerc, G. Greub Clinical Microbiology and Infection

Overview of cefixime use in community-acquired infections

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J.L. Balcázar Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study)

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing L. Bissonnette, M.G. Bergeron Clinical Microbiology and Infection Volume 16, Issue 8, Pages 1044-1053 (August 2010) DOI: 10.1111/j.1469-0691.2010.03282.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 The need for speed in diagnostic microbiology. From patient admission to the making of decisions orienting the management or treatment, gains in time to delivery of results may translate into a better healthcare system. For a life-threatening syndrome such as sepsis, rapid identification of the microbial pathogen in less than 6 h is especially critical for the proper management and treatment of a patient, resulting in lower morbidity and mortality. Clinical Microbiology and Infection 2010 16, 1044-1053DOI: (10.1111/j.1469-0691.2010.03282.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions